2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China
Open Access
- 16 June 2025
- journal article
- review article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (6) , 31384
Abstract
The Working Group on Cardiopulmonary Bypass and Extracorporeal Life Support of China National Center for Cardiovascular Quality Improvement presents evidence-based guidelines on patient blood management for adult cardiac surgery under cardiopulmonary bypass. These guidelines aim to promote patient blood management programs, reduce blood loss and allogeneic transfusion, and improve patient outcomes. The Guidelines Panel includes multidisciplinary experts. Based on prior investigation and the patient, intervention, comparison, outcome (PICO) principles, thirteen questions from four aspects were selected, including priming and fluid management during cardiopulmonary bypass, anticoagulation and monitoring during cardiopulmonary bypass, peri-cardiopulmonary bypass blood product infusion, and autologous blood infusion. Systemic reviews of the thirteen questions were performed through literature research. Recommendations were generated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system and reviewed and refined by all the Guideline Panel members. A total of 19 recommendations were finally approved after five expert meetings between 2023 and 2024. By implementing these recommendations, perfusionists and medical staff involved in cardiac surgery can optimize patient blood management, effectively decrease allogeneic blood transfusion rates, minimize perioperative bleeding, and ultimately improve the prognosis in adult patients undergoing cardiac surgery with cardiopulmonary bypass.Keywords
Funding Information
- Chinese society of cardiothoracic and vascular anesthesiology Transfusion-Free Program (2022-5)
- 1•3•5 Outstanding Development Program of West China Hospital of Sichuan University (2017-120)
- National Key Research and Development Program of China (2023YFC2410305)
- National Key Clinical Specialty Development Program of China (2021)
This publication has 137 references indexed in Scilit:
- Method to Calculate the Protamine Dose Necessary for Reversal of Heparin as a Function of Activated Clotting Time in Patients Undergoing Cardiac SurgeryThe Journal of ExtraCorporeal Technology, 2013
- A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care UnitNew England Journal of Medicine, 2004
- Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trialThe Annals of Thoracic Surgery, 2004
- Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volumePerfusion, 2003
- Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgeryJournal of Cardiothoracic and Vascular Anesthesia, 2001
- Modified Ultrafiltration Reduces Morbidity After Adult Cardiac OperationsCirculation, 2001
- Cell Saver, Ultrafiltration and Direct Transfusion: Comparative Study of Three Blood Processing TechniquesThe Thoracic and Cardiovascular Surgeon, 2001
- Efficacy of autologous fresh whole blood or platelet‐rich plasma in adult cardiac surgeryTransfusion, 1995
- Heparin rebound phenomenon??? much ado about nothing?Blood Coagulation & Fibrinolysis, 1992
- The Elimination from Plasma of Intravenous Heparin An Experimental Study on Dogs and HumansActa Medica Scandinavica, 1963